Notice Regarding Company Split Of Asian Business, Execution Of Share Transfer Agreement And Shareholders’ Agreement with Marubeni Global Pharma Corp
April 1 (Reuters) - Sumitomo Pharma Co Ltd 4506.T: SUMITOMO PHARMA CO LTD - NOTICE REGARDING A COMPANY SPLIT OF ASIAN BUSINESS AND EXECUTION OF A SHARE TRANSFER AGREEMENT AND A SHAREHOLDERS'AGREEMENT SUMITOMO PHARMA CO LTD - WILL RECEIVE APPROXIMATELY 45 BILLION YEN FOR SHARE TRANSFER SUMITOMO PHARMA CO LTD - IN ADDITION, SCHEDULED TO RECEIVE APPROXIMATELY 27 BILLION YEN AS CONSIDERATION FOR TRANSFER OF REMAINING 40% SHARES Source text: ID:nTSpa7b9e5 Further company coverage: 4506.T
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)